Get the answers you need at Westonci.ca, where our expert community is dedicated to providing you with accurate information. Connect with a community of experts ready to provide precise solutions to your questions on our user-friendly Q&A platform. Connect with a community of professionals ready to provide precise solutions to your questions quickly and accurately.
Sagot :
Clinical practitioners in the United States continue to underutilize inhaled corticosteroids in the management of mild-to-moderate adult asthma.
In a cohort of patients aged 18 and older with FEV(1) values between 60% and 100% of predicted normal, the aim of this experiment was to determine the clinical effects, health-related quality of life, cost, and cost-effectiveness of inhaled corticosteroid therapy.
We compared the use of inhaled corticosteroid therapy along with quick relievers (such as short-acting beta-agonists) on an as-needed basis to the use of quick relievers alone.
To predict symptoms, acute exacerbations, quality-adjusted life years (QALYs), health care expenses, and cost-effectiveness, evaluated in both dollars per QALY gained and dollars per symptom-free day gained, a mathematical simulation model was created.
Learn more about corticosteroids:
https://brainly.com/question/28255810
#SPJ4
The complete question is '' what is the cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model''.
Thanks for stopping by. We strive to provide the best answers for all your questions. See you again soon. Thanks for using our platform. We aim to provide accurate and up-to-date answers to all your queries. Come back soon. Find reliable answers at Westonci.ca. Visit us again for the latest updates and expert advice.